Stephen Ubl, PhRMA president and CEO (Adrien Villez for Endpoints News)
January 12, 2024 03:20 PM EST
Pharma
FDA+

PhRMA, Eli Lil­ly, oth­er drug com­pa­nies push back on FDA's draft guid­ance about com­mu­ni­cat­ing off-la­bel use

Lia DeGroot

Big Phar­ma is push­ing back on draft guid­ance pub­lished by the FDA this fall that aims to clar­i­fy how …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

IGM Bio­sciences’ au­toim­mune piv­ot lasts three months af­ter in­ter­im da­ta dis­ap­point

Ver­sant un­veils Light Horse with $62M and a part­ner­ship with No­var­tis

Shore­line cuts staff as its part­ner­ship with Gilead­'s Kite is now in flux

Aio­los team re­unites with $411M for new biotech with obe­si­ty drugs from Chi­na

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Bay­er says elin­zane­tant quelled hot flash­es in women un­der­go­ing can­cer treat­ment

A service from the Financial Times